The U.S.-China Economic and Security Review Commission will hold an open public hearing Jan. 26 in Washington, D.C. to explore patterns of Chinese investment in the U.S. and  implications for U.S. policymakers. Topics will include China’s increasing investments in strategic sectors, Chinese state-owned companies claiming sovereign immunity in U.S. courts, and duress acquisitions of U.S. entities by Chinese firms. The hearing will also cover the activities of Chinese companies listed on U.S. stock exchanges, assessing implications for U.S. investors and the U.S. economy at large.


Cookie Consent

We use cookies on our website. By continuing to use our website, you agree to the Privacy Policy and Terms of Use.